Background: Electrocardiograms in elite endurance athletes sometimes show bizarre patterns suggestive of inherited channelopathies (Brugada syndrome, long QTc, catecholaminergic polymorphic ventricular tachycardia) and cardiomyopathies (arrhythmogenic right ventricular cardiomyopathy, hypertrophic cardiomyopathy) responsible for unexpected sudden cardiac death. Among other methods, genetic analyses are required for correct diagnosis.
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(Brugada syndrome, long QT syndroms, idiopathic ventricular fibrillation, polymorphic ventricular tachycardia) could be the causes for sudden cardiac death [11] [12] [13] [14] . In the absence of any echocardiographic structural abnormalities, establishing the diagnosis is often difficult to achieve when the electrocardiograms of trained athletes often present findings considered abnormal by usual standards. The correct management includes detailed athlete's history, 12-lead electrocardiography, additional tests (i.e. 24h heart rhythm ambulatory monitoring, Ajmaline provocative test) and sometimes, targeted genetic analysis [15] [16] [17] [18] . A genotype -phenotype analysis based on the electrocardiographic findings in elite endurance athletes was the purpose of our study.
Material and methods

Studied population Endurance athletes
347 intensively trained athletes (Caucasians) participants in sports activity with high cardiovascular burden were chosen [19, 20] . The sports were canoeing, rowing, football, hockey, tennis, swimming, and athletics. There were 190 senior and 157 junior athletes [20] . Senior athletes had trained intensively for 20-27 h /week for > 5 years and participated in World Championships and Olympic Games. The junior primary and final selections were at the age of 12-14 years old and 17-18 years old respectively.
Sedentary healthy population (controls)
The apparently normal (asymptomatic, normal physical examination, no detectable cardiovascular risk factors) sedentary population [21, 25] of 505 subjects and participants were investigated for work eligibility in our Cardiology Department (Auto/Work License). Exclusion criteria for control subjects were coronary artery disease, valvular / congenital diseases, cardiomyopathies, heart failure, and cardiovascular drug therapy. None of the athletes and controls received any drugs. The protocol was approved by the Hospital Ethical Committee and informed consents were obtained from all subjects who enrolled in the study.
Study protocol
Clinical examination
The cardiologic examination included detailed personal and family history and complete physical examination [9, 11] .
Standard 12 -lead electrocardiography
ECG was recorded with a digital machine (MACC 5500 GE Medical Systems, Milwaukee, Wisconsin, USA) in all athletes and controls. ECG measurements were computer -assisted and independently manually controlled by two experienced electrocardiographic readers (CM,IS) unaware of clinical data and sports categories [22] [23] [24] 36] . Disagreements regarding the measurements were resolved by consensus. An average of 3-5 cardiac cycles was used. Tracings were obtained > 24 hours after the last athletic activity. Recordings in higher right precordial V1-V3 intercostal spaces (six new positions: -1V1 to -1V3; -2V1 to -2V3) to detect the Brugada signs were performed in all athletes and sedentary normal subjects [26, 27, 32] . Ajmaline provocative test in standard 12-lead ECG and upper right V1-V3 precordial leads positions was indicated according to the current guidelines [33, 61] . ECG parameters were evaluated according to actual criteria [22] [23] [24] 36] .
Standard electrocardiographic variables. Definitions.
We used the current electrocardiographic criteria [22, 23] including: 1) normal sinus rhythm: heart rate 60-100 bpm; 2) normal QTc (Bazett) ≤ 0.39"in men , ≤ 0.44" in women;
3) borderline normal ECG : RSR' or rSr' pattern in V1 lead (QRS duration < 0.10", height < 7mm; r'wave < 2mm and r'< r; juvenile T wave (inversed T in V1-V3 precordial leads; usually deep < 2mm); 4) Q wave (≤ 0.5 mm in lead III; normal duration ≤ 0.03"and height ≤ 0.4 mm in all leads); 5) J wave (Osborn; deflection that distort the QRS-ST junction usually in II,III,V4 to V6 leads); 6) upright T wave (beyond normal ≤ 0.5 mm in limb leads and ≤ 0.10 mm in precordial leads); 7) bifid T wave (T wave with two peaks different from U wave; possible delayed right ventricular repolarization); 8) ST-segment, normally isoelectric (within normal limits: elevation and depression ≤0.1mm in limb leads, elevation ≤0.3 mm in V1-V3 precordial leads; measurements at 80 ms from the J point).
ECG patterns in highly trained endurance athletes [41] [42] [43] [44] [45] [47] [48] [49] 54] A. Distinctly abnormal ECG, strongly suggesting cardiovascular disease: 1) striking increase in R or S wave voltage (≥35mm) in any lead;
2) Q waves ≥4 mm in depth in ≥ 2 leads; 3) inverted T wave > 2mm in ≥2 leads; 4) left bundle branch block; 5) marked left (≥-30º) or right (≥110º) QRS axis deviation; 6) Wolff-Parkinson-White pattern. B. Mild abnormal ECG 1) increased R or S wave voltage (30 to 34mm) in any lead;
2) Q waves 2 to 3 mm in depth, in ≥ 2 leads; 3) T wave flat, minimally inverted or particularly tall (i.e.≥15mm) in ≥2 leads; 4) abnormal R wave progression in the anterior precordial leads; 5) left atria enlargement; 6) short PR interval (≤0.12"). C. Normal ECG or ECG with minor alterations (athlete's heart syndrome): 1) PR interval duration >0.20"; 2) R or S voltage, 25 to 29mm; 3) early repolarization; 4) RSR'pattern in V1 ,V2 of 0.12" in duration); 5) sinus bradycardia < 60 bpm.
For the Brugada syndrome: long QT syndrome, polymorphic ventricular tachycardia, ARVC and HCM the commonly adopted clinical and electrocardiographic criteria were used in the study [30, 31, 34, 35, [37] [38] [39] [40] [47] [48] [49] .
Holter monitoring, indicated when necessary [28, 29, 46] .
Echocardiography
Echocardiographic, standard Doppler and TDI analyses were performed by digital ultrasound machine (VIVID 3, GE Medical Systems, Milwaukee, Wisconsin, USA; Aloka α Grosound, Japan).
Measurements were done according to ASE criteria. (58)
Genetic study
Subjects with positive or questionable ECG patterns of inherited channelopaties / cardiomyopaties were enrolled.
Techniques. Genomic DNA (200µl blood) -QiAampDNA blood minikit (Qiagen).
SCN5A and KCN genetic mutations studies were performed with Multiplex Ligation-Dependent Probe Amplification (MLPA, MRC Holland). SALSA P108 for SCN5A and SALSA P114 for KCNQ1, KCNH2, KCNE1, KCNE2 , kit were used.( 50,51,52,53,54,55,56)
Statistics
Results are expressed in mean value ± SD. Proportions were compared with the chi square test, where appropriate.
Results
Clinical characteristics of studied population
We examined 347 athletes (seniors 190; juniors 157). 
Electrocardiographic findings
All electrocardiographic parameters in athletes (n=347) are summarized in Table 2 .
Senior athletes. RSR' pattern in high V1-V3 precordial leads in 45 athletes (23.68%) associated with ST elevation in 34 cases (17.89%). Coved ST segment elevation, suggestive for Brugada 1 sign in one lead only (standard/high V1; questionable Brugada sign) in 5 of ST elevation subjects. Provocative Ajmaline test -negative in 2 cases and refused by 3 subjects. Complex premature ventricular beats (Holter, 24h), were found in 23 athletes (12.10%).
Brugada sign1, V1-V3 standard / high, one (0.52%) subject; EP induced ventricular tachycardia.
Epsilon wave, was found in 3 athletes (1.57%). Bifid T wave associated to prolonged QTc (0.48"± 0.09") was found in 8 athletes (4.21%).
There was a normal echocardiographic exam except for one epsilon subject and for ARVC echo data, diagnosed by MRI. No., number, BSA, body surface area, BP, blood pressure,systolic/diastolic; HR, heart rate.
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Junior athletes. RSR' (R'height 2.18±0.56mm) recorded in the V1-V3 upper precordial leads, 26 cases (16.56%); questionable Brugada sign in 9 athletes (5.73%). Ajmaline provocative test was negative in 4 cases and refused by 5 subjects. In juniors, the highest incidence of 12-leads ECG abnormalities were J wave elevation (1.32±0.63mm), 34c (27.38%) and ST-segment convex injury elevation (elevation height 2.39±0.79mm, measured at 80ms from J point) pattern, 39c(24.84%) ( Table 2) . Bifid T waves associated to prolonged QTc intervals (0.56"± 0.07") were recorded in 5 subjects ( 
Normal sedentary subjects
According to the decades of age, 505 subjects` ECG characteristics are shown in Table 3 . In the first 2 columns, 200 normal subjects (13-20y; 21-30y) match the athletes' age. In this subgroup (13-30 y; n=200) the ECG SR, sinus rhythm; Arrhyth, arrhythmias; WPW, Wolff-Parkinson-White; Std RSR', standard RSR' in V1-V3 leads; High RSR', higher intercostal spaces; ST-segm, ST-segment elevation myocardial injury like; T>15mm, positive T wave >15mm; * p < 0.01; NS, insignificant 
Genetic analysis
227 athletes (114 seniors, 113 juniors) and 35 normal sedentary subjects were selected. The 12-lead ECG inclusion criteria for genetic analysis were: 1) Brugada sign; 2) questionable Brugada sign; 3) high RSR" precordial leads V1-V3 and R'>2mm >R and associated with complex PVB; 4) inverted T waves (>2 mm) in > 2 leads; 5) bifid T wave with distinct two peaks associated or not with prolonged QTc interval; 6) ST-segment convex elevation, injury like pattern; 7) epsilon waves. In Fig. 3 the percent of the ECG abnormalities in senior and junior athletes selected for genetic analyses are presented.
N.B.
Number, first % (related to age decade group) and second % (related to the 505 controls). Seven junior athletes had mutations on KCN genes: KCNQ1 (n2), KCNE2 (n1), KCNH2 (n4); all mutations were missense (duplication) on exon 2 (n3), exon 4 (n2), exon 18 (n1) and exon 19 (n1). One of these athletes whose electrocardiograms are presented in Figure 4b ,4b' had 2 mutations on 2 different KCN genes (KCNQ1, KCNH2) (Fig. 4a) .
None of the senior athletes selected for genetic analysis had gene mutations except for one with SCN5 duplication, exon 1 (Fig. 6) ; normal clinical exam and negative specific tests for Brugada syndrome were done in this case. No SCN5A mutations in Brugada sign1 athlete and EP induced ventricular tachycardia. e1  e2  e3  e4  e6  e7  e9  e11  e15  e17  e19  e21  e22  e23  ex25  e27  e28  C01  C02  C03  C04  C05  C06  C07  C08  C09  C10  C11 One senior athlete had missense mutation (duplication) on SCN5A gene, exon1 (Fig. 6) . e1  e2  e3  e4  e6  e7  e9  e11  e15  e17  e19  e21  e22  e23  ex25  e27  e28  C01  C02  C03  C04  C05  C06  C07  C08  C09  C10  C11  C12 Gene mutations and electrocardiographic associated abnormalities in athletes are summarized in Table 4 Genes mutations and ECG abnormalities in 7 athletes.
In sedentary normal subjects, one subject with Brugada 1 sign and his healthy and electrocardiographically normal mother had similar mutations (deletion) on SCN5A gene, exon1. An epsilon sedentary normal subject (decade 31-40y) had MRI documented ARVC; no gene mutations were detected, but his clinically and electrocardiographically normal sister had missense mutation (deletion) on SCN5A, exon1.
Discussions
Since 2004 we have been interested to evaluate the ECG patterns in highly trained athletes from different level of training (juniors, seniors) involved in sports with intensive cardiovascular burden. We observed ECG tracings with bizarre and unexpected QRS and ST-T aspects, different from the "classically" ECG patterns described in elite endurance athletes [20,58-61].
The main purpose of our study was to find out whether these ECG (V1-V3) morphologies (possible delayed impulse conduction in the right ventricle, including RVOT) were linked to genetic mutations responsible for inherited channelopathies (i.e. Brugada syndrome, RVOT ventricular tachycardias) and cardiomyopathies (i.e.ARVC). Gene mutations for HCM in subjects with specific ECG abnormalities were searched for.
The senior and junior athletes' electrocardiograms were analyzed separately and compared to sedentary normal, aged matched persons' ECG data. In seniors, the RSR' pattern dominate with R'>2mm in higher V1-V3 leads; 34% of RSR' athletes had ST-segment elevation, resembling the Brugada sign present in only one lead and V1 (questionable Brugada sign) in few cases. Possible abnormal (delayed) impulse conduction into RVOT has been considered regarding this mechanism [49] . The highest incidence of junior ECG abnormalities was elevated J wave and convex injury like ST-segment elevation in V1-V3,V4 leads (standard, high). In junior athletes, bifid T wave associated to moderately long QTc interval arose the question of a possible abnormal prolonged ventricular repolarization. Few of our controls had similar ECG abnormalities.
A molecular substratum not evident in ordinary life but exacerbated by strenuous training could be the cause of athletes' ECG abnormalities.
To support this hypothesis we focused on the relation between the ECG patterns suggestive of Brugada syndrome, long QT syndrome, HCM, ARVC and specific genetic study.
The genetic analysis referred to mutations in SCN5A and LQTS genes and genes responsible for inherited cardiomyopathies.
Junior athletes had 7 mutations in LQTS genes (KCNQ1, KCNH2, KCNE2) one of them with two KCN mutations, on KCNQ1 and KCNH2. All seven abnormalities were missense (duplication) mutations on exons 2 ,4, 18 and 19.
Three controls had SCN5A mutations: two of these (deletions) were in 1 Brugada person and his healthy mother. Interestingly, a family member (healthy sister) of a documented ARVC patient had a SNC5A mutation (duplication). All SCN5A mutations were missense, heterozygote type.
No specific molecular abnormalities were found in other athletes.
The mutations identified by MLPA will be detailed by complex genetic analyses such as the sequence techniques.
Conclusions
The electrocardiogram in athletes performing high endurance training is sometimes strange, looking like inherited channelopathy and cardiomyopathy ECG patterns. Specific tests for correct diagnosis are frequently necessary. Genetic analysis, the "last step" to diagnosis sometimes gives surprising and unexpected information, whose significance needs to be investigated. Complex molecular techniques could bring forward details of these genetic mutations identified in elite athletes with "frequently encountered 12-lead ECG athletics patterns".
The next and future medical approach regarding the athletic performance is still a challenge for the scientific medical community.
